This section presents CryoVit as an engineering platform: SmF bioreactors, purification systems, microdrop technology and process control combined into one chain from cultivation to the finished delivery format.
Work with macroporous and ion-exchange resins, an extraction and regeneration cycle, a transition from laboratory to small-scale production and precise fractionation before crystallization or microgranulation.
A key machine in the CryoVit platform: from purified solution to a calibrated microdrop, instant freezing and preparation for lyophilization as the basis of the final product format.
System with washing and sterilization, preparation of nutrient media, flexible management of growth phases and remote AI monitoring. It is this closed cycle that enables pharmaceutical purity and a high yield of erinacins, cordycepin and EPS fractions.
The bioreactor moves cultivation from a seasonal and unstable regime to a controlled environment with lower contamination risk, fewer raw-material fluctuations and better process discipline.
pH, temperature, oxygen and medium composition allow the process to target not only biomass, but also specific metabolites such as erinacins, cordycepin and extracellular polysaccharides.
The SmF script shortens the cycle to 7-14 days, scales better and makes the product more accessible to the B2B segment without losing purity and reproducibility.
Open the detailed pages for purification, microdrop formation and bioreactor cultivation to see how each unit fits into the wider CryoVit production chain.
